MassIVE MSV000100988 - An orally active dual CBP/p300 degrader targets core dependencies of multiple myeloma

Read full text
Authors: Christoper Ott, Wilhelm Haas
Cited by: 0

Fields of Study & Subjects

Protein Degradation and Inhibitors Multiple Myeloma Research and Treatments Histone Deacetylase Inhibitors Research

Publication details

Journal / source
UC San Diego
Publication date
1 January 2026
Language
EN
Document type
Dataset